Pfizer (PFE) Non-Current Assets (2009 - 2026)
Pfizer (PFE) recorded Non-Current Assets of $159.77 billion in Q2 2026, down 1.6% from $162.39 billion a year earlier and down 3.3% from the prior quarter.
Pfizer (PFE) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer reported Non-Current Assets of $3.3 billion, up 2.3% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $3.22 billion in FY2024 (+7.1%), $3.01 billion in FY2023 (-0.2%), $3.01 billion in FY2022 (-15.4%) and $3.56 billion in FY2021 (+5.4%).
- Quarterly Non-Current Assets has ranged from $3.01 billion in Q4 2023 to $178.68 billion in Q1 2024 over the past five years.
- On a year-over-year basis, Non-Current Assets rose in three of the last seven quarters, with an average decline of 2.4%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 22.4% in Q1 2024, against a decline of 15.4% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $165.18 billion (Q1 2026), $3.3 billion (Q4 2025) and $162.08 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 59.06 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 159.77 Bn |
| Mar 29, 2026 | 165.18 Bn |
| Dec 31, 2025 | 3.30 Bn |
| Sep 28, 2025 | 162.08 Bn |
| Jun 29, 2025 | 162.39 Bn |
| Mar 30, 2025 | 162.17 Bn |
| Dec 31, 2024 | 3.22 Bn |
| Sep 29, 2024 | 176.25 Bn |
| Jun 30, 2024 | 178.37 Bn |
| Mar 31, 2024 | 178.68 Bn |
| Dec 31, 2023 | 3.01 Bn |
| Sep 30, 2023 | 36.95 Bn |
| Jul 2, 2023 | 146.82 Bn |
| Apr 2, 2023 | 145.92 Bn |
| Dec 31, 2022 | 3.01 Bn |
| Sep 30, 2022 | 35.20 Bn |
| Jul 3, 2022 | 127.82 Bn |
| Apr 3, 2022 | 129.58 Bn |
| Dec 31, 2021 | 3.56 Bn |
| Oct 3, 2021 | 39.45 Bn |
Pfizer Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();